A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status
NCT ID: NCT07038317
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
120 participants
INTERVENTIONAL
2026-01-15
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Does receiving e-cigarette education messages presented using a source (expert or peer) and sidedness (one or two-sided) optimized for the current vaper group influence vaping cessation among young adults who vape daily?
2. Does receiving e-cigarette education messages presented using a source (expert or peer) and sidedness (one or two-sided) optimized for the non-vaper group influence vaping initiation among young adults who are susceptible to vaping? Participants will be randomly assigned to either the treatment (receiving messages tailored to one's vaping status) or the control (receiving non-tobacco messages) condition and receive SMS three times per week over the course of 6 months. They will complete self-report assessment and show salivary cotinine results for nicotine testing at 4 timepoints.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Responses to E-cigarette Message Source and Presentation
NCT06274723
Text Messages in Preventing Tobacco Use in Young Adults
NCT03457480
Responses to Message Source and Presentation Using Psychophysiology
NCT06269003
Impact of E-Cigarette Prevention Messages on Adolescents
NCT05985538
Text Message Quit Vaping Intervention for Young Adults
NCT04251273
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
Participants in the treatment arm will receive e-cigarette education messages with source and sidedness optimized to one's vaping status.
Intervention
Intervention involves e-cigarette education messages tailored to participants' vaping status that will be sent out in SMS via text messaging three times per week over the course of 6 months.
Control
Participants in the control arm will receive messages about sun safety.
Control
Participants will receive non-tobacco messages (messages about sun safety) three times per week over the course of 6 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
Intervention involves e-cigarette education messages tailored to participants' vaping status that will be sent out in SMS via text messaging three times per week over the course of 6 months.
Control
Participants will receive non-tobacco messages (messages about sun safety) three times per week over the course of 6 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fluent in English
* Not currently using tobacco products other than e-cigarettes at the time of enrollment
* Have a mobile phone to send and receive text messages
Exclusion Criteria
* Not being fluent in English
* Currently using tobacco products other than e-cigarettes
* Not having a mobile phone
18 Years
24 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
University of Hawaii
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Donghee Nicole Lee
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Hawaii Cancer Center
Honolulu, Hawaii, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.